These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 187365)

  • 1. [Changes in serum C-peptide in glucose tolerance test; with special reference to diabetes and insulinoma].
    Iwaya S; Odagiri R; Tasaka J; Hirata U
    Horumon To Rinsho; 1976; 24(5):443-8. PubMed ID: 187365
    [No Abstract]   [Full Text] [Related]  

  • 2. [Serum C-peptide level in metabolically healthy probands, diabetics and patients with island cell tumors].
    Krause U; Cordes U; Beyer J
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():794-5. PubMed ID: 196433
    [No Abstract]   [Full Text] [Related]  

  • 3. [The C-peptide suppression test in normal persons and insulinoma patients: an attempt to evaluate its use in functional diagnosis (author's transl)].
    Mandelkow H; Goetz K; Kühnau J
    Klin Wochenschr; 1981 Nov; 59(21):1209-15. PubMed ID: 6273644
    [No Abstract]   [Full Text] [Related]  

  • 4. Insulinoma with special features.
    Ramachandran A; Mohan V; Snehalatha C; Bharani G; Nagarathinam C; Viswanathan M
    J Assoc Physicians India; 1987 Jun; 35(6):450-1. PubMed ID: 2820922
    [No Abstract]   [Full Text] [Related]  

  • 5. [Discordance between peripheral blood levels of insulin and C-peptide in a case of insulinoma].
    Grimaldi A; Brochet E; Bosquet F; Benoliel JJ; Andreassian J; Carayon A
    Presse Med; 1984 Sep; 13(31):1901-2. PubMed ID: 6091094
    [No Abstract]   [Full Text] [Related]  

  • 6. Lack of diabetogenic action of calcitonin in subjects affected by insulinoma.
    Passariello N; Paolisso G; Iannuzzi F; Pizza G; Marrazzo G; Sgambato S; D'Onofrio F
    Diabete Metab; 1989; 15(2):88-92. PubMed ID: 2544469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pancreatic function tests].
    Abe M; Ikeda Y; Yaginuma M; Shimizu N
    Nihon Rinsho; 1969 Feb; 27(2):291-300. PubMed ID: 4306418
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of a common standard for comparison of insulin C-peptide measurements by different laboratories.
    Caygill CP; Gaines Das RE; Bangham DR
    Diabetologia; 1980 Mar; 18(3):197-204. PubMed ID: 6245983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnosis of insulinomas. Determination of insulin, C-peptide and proinsulin in blood to differentiate between endogenous and exogenous hyperinsulinism].
    Hanssen KF; Torjesen PA; Heding LG
    Tidsskr Nor Laegeforen; 1981 Dec; 101(34-36):1957-60. PubMed ID: 6280336
    [No Abstract]   [Full Text] [Related]  

  • 10. Glucose-induced GIP levels in patients with insulinoma.
    Tamburrano G; Lala A; Mauceri M; Leonetti F; Andreani D
    Horm Metab Res; 1984 Dec; 16 Suppl 1():200-3. PubMed ID: 6099816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [C-peptide from proinsulin e--theory and practice].
    Malmquist J; Lindgärde F; Almér LO; Johansson E
    Lakartidningen; 1982 Jul; 79(30-31):2716-9. PubMed ID: 6755106
    [No Abstract]   [Full Text] [Related]  

  • 12. [Changes in CPR and blood metabolites during glucose loading in healthy subjects and patients with various diseases].
    Sakamoto N; Hotta G
    Horumon To Rinsho; 1977 Oct; 25(10):1081-9. PubMed ID: 589807
    [No Abstract]   [Full Text] [Related]  

  • 13. [Insulinoma--diagnostic aspects].
    Pelkonen R; Taskinen MR; Rauste J
    Duodecim; 1974; 90(1):22-33. PubMed ID: 4368163
    [No Abstract]   [Full Text] [Related]  

  • 14. C-peptide suppression test for insulinoma.
    Service FJ; Horwitz DL; Rubenstein AH; Kuzuya H; Mako ME; Reynolds C; Molnar GD
    J Lab Clin Med; 1977 Jul; 90(1):180-6. PubMed ID: 194989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose intolerance in a patient with insulinoma. Report of a case.
    Christiansen J; Munkgaard S
    Acta Chir Scand; 1974; 140(7):578-80. PubMed ID: 4376322
    [No Abstract]   [Full Text] [Related]  

  • 16. [New index for the diagnosis of insulinoma--serum C-peptide immunoreactivity (CPR) and CPR/blood sugar ratio].
    Tanaka S; Matsumoto K; Kitamura T; Horiuchi S; Miyashita M
    Horumon To Rinsho; 1977 Apr; 25(4):415-8. PubMed ID: 194738
    [No Abstract]   [Full Text] [Related]  

  • 17. Diabetes mellitus in pancreatic cancer follow-up.
    Fogar P; Pasquali C; Basso D; Sperti C; Panozzo MP; Tessari G; D'Angeli F; Del Favero G; Plebani M
    Anticancer Res; 1994; 14(6B):2827-30. PubMed ID: 7532931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin and C-peptide in plasma and tumor of insulinoma patients.
    Ohneda A; Sakai T; Kobayashi T; Nihei J
    Tohoku J Exp Med; 1983 Jan; 139(1):73-81. PubMed ID: 6301101
    [No Abstract]   [Full Text] [Related]  

  • 19. [Dynamics of the glucagon and C-peptide content in Itsenko-Cushing disease].
    Arapova SD; Zavadskiĭ PS; Marova EI
    Sov Med; 1980; (2):42-7. PubMed ID: 6987746
    [No Abstract]   [Full Text] [Related]  

  • 20. [Insulin assay in insulinoma].
    Zeng XJ
    Zhonghua Wai Ke Za Zhi; 1984 Jan; 22(1):13-8, 62. PubMed ID: 6097422
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.